No Data
Express News | Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Press Release: Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Akari Therapeutics Merges With Peak Bio to Advance Autoimmune Treatments
Express News | Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
Press Release: Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
Express News | Akari Therapeutics Files Prospectus for Resale by Selling Shareholders of up to 21.56 Bln Ordinary Shares - SEC Filing
No Data
No Data